13 active trials 12 recruiting 8 Phase 3 26 disease areas 3 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Primary and study completion pushed from Jun 2027 to Dec 31, 2028
Also in this update: Interventions modified
Cancer Research UKPhase 1/2 NCT05944237 Registry history of NCT05944237 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1/2 | 5 | |
| Phase 2/3 | 8 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT07440290 | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult… | Haematological Malignancy | Recruiting | 2026-08-17 |
| NCT05722886 | DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare… | Haematological Malignancy | Recruiting | 2026-07-01 |
| NCT05786716 | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult… | Haematological Malignancy | Recruiting | 2025-12-02 |
| NCT05768178 | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult… | Haematological Malignancy | Recruiting | 2025-11-24 |
| NCT05770037 | DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult… | Haematological Malignancy | Recruiting | 2025-11-24 |
| NCT05770102 | DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young… | Malignancy | Recruiting | 2025-11-24 |
| NCT05770544 | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young… | Haematological Malignancy | Recruiting | 2025-11-24 |
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring… | Solid Tumour | Recruiting | 2025-11-24 |
| Phase 1/2 | ||||
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | Neoplasms | Recruiting | 2026-10-01 |
| NCT05272709 | TT-702 in Patients With Advanced Solid Tumours. | Advanced Solid Tumors | Recruiting | 2026-08-12 |
| NCT06380816 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | Advanced Solid Tumours | Recruiting | 2026-05-08 |
| NCT06045910 | A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies | Lymphoma, Non-Hodgkin | Recruiting | 2025-07-28 |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | Bladder Cancer | Active, Not Recruiting | 2025-08-11 |
Colorectal Cancer (7) · Head & Neck Cancer (6) · Lung Cancer (6) · Ovarian Cancer (5) · Gastric Cancer (4) · Glioma (4) · Melanoma (4) · Non-Small Cell Lung Cancer (NSCLC) (4) · Pancreatic Cancer (4) · Bladder Cancer (3)